Advances in the pathogenesis and treatment of thyroid cancer

Nader N. Hanna, Patrick C. McGrath, David A. Sloan, Daniel E. Kenady

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Thyroidectomy remains the mainstay of treatment for thyroid carcinoma. The extent of surgical resection, however, remains controversial as most patients will have excellent long-term prognosis and because some of the standard staging and prognostic information are not available at the time of surgical resection. The different staging and risk group definitions for thyroid carcinoma are not superior to the Tumor-Node-Metastasis classification of the American Joint Commission in Cancer (AJCC), which is universally available and accepted and should be used to report treatment outcomes. Recent advances in the molecular pathogenesis of thyroid malignancy will help identify high-risk patients who would benefit from aggressive surgical resection and adjuvant treatment.

Original languageEnglish
Pages (from-to)42-47
Number of pages6
JournalCurrent Opinion in Oncology
Issue number1
StatePublished - 1999

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Advances in the pathogenesis and treatment of thyroid cancer'. Together they form a unique fingerprint.

Cite this